Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance. (2013)

First Author: Chell V


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2012.319

PubMed Identifier: 22869148

Publication URI: http://europepmc.org/abstract/MED/22869148

Type: Journal Article/Review

Volume: 32

Parent Publication: Oncogene

Issue: 25

ISSN: 0950-9232